One Research Firm Puts Regenerative Medicine at $41 Billion, Heading for $162 Billion. Dr. David Borenstein on Why the FDA Keeps Cracking Down on Unproven Clinics.
DelveInsight, a market-research firm, estimates the global regenerative medicine market at about $41 billion in 2025 and projects roughly $162 billion by 2034. The FDA has spent years pursuing clinics selling unapproved stem cell products, most recently in a January 2025 warning letter to a Pompano Beach, Florida manufacturer. Dr. David Borenstein, a physician who offers regenerative treatments, says patients should ask what a product is before they book.




























![14-1011-039 print 8x10 b&w "D" Ward, US Naval Hospital, Quantico, VA. [Ward][Nurses][Corpsmen][Patients] Navy Medicine Historical Files Collection - Facilities](/assets/photos/travel-nursing-permanent-1600w.jpg)









